EcoR1 Capital
ecor1cap.com
Actively hiring
Biotechnology
Venture Capital
Hedge Funds & Alternative Investments
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Portfolio
Companies
70
16 of them startups
Hiring now
14
companies with open roles
Rounds in 12 months
1
$257M raised
Its companies, the freshest money firstAll in Startups
CellaresSeries D $257M · 5 mo ago
Denali TherapeuticsVenture round $499.7M · 2 yr ago
Gossamer BioVenture round $212.1M · 3 yr ago · 1 role
Kumquat BiosciencesVenture round $30M · 5 yr ago
NeurogeneVenture round $69M · 5 yr ago
NUVATION BIOVenture round $275.3M · 7 yr ago
aTyr PharmaVenture round $45.8M · 9 yr ago
One moment, please...Venture round $4.7M · 10 yr ago
Nurix Therapeutics, Inc38 roles
Centessa Pharmaceuticals29 roles
Freenome22 roles
Scholar Rock20 roles
Eikon Therapeutics17 roles
Syndax16 roles
ElevateBio10 roles
relay_tx9 roles
artivabio9 roles
Kura Oncology6 roles
Intelliatx5 roles
Collegium Pharmaceutical5 roles
Editas Medicine1 role
Atarabio
PLEASE READ THIS AG
scorpiontx.com
Overview
EcoR1 Capital is a biotech-focused investment fund that backs companies developing new medicines. It invests in public and private biotechnology companies, including late-stage private rounds, with a science-driven approach centered on clinical-stage drug developers. The firm was founded in 2013 by Oleg Nodelman and is based in San Francisco, California.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
"The true sign of intelligence is not knowledge but imagination."
10-50 est. staff
357 Tehama Street, Floor 3, San Francisco, CA 94103